Dominican Republic

A snapshot of PrEP scale-up, registration and resources for the Dominican Republic.

100-300

Estimated Number of Current PrEP Users

Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.

150

PEPFAR PrEP Target in COP 2019

Targets are set by PEPFAR country teams on an annual basis. Targets do not indicate funding is available for PrEP.

Data Updated: December 31, 2018

Drug Registration Status

Gilead's Truvada (TDF/FTC) registration

Not submitted

Generic versions of TDF/FTC for prevention

Not submitted

Types of Delivery Projects

Large-scale implementation initiative — funded/implementer involvement and investment in some or all steps related to comprehensive introduction that may or may not use government clinics as the primary service delivery point – e.g., Kenya’s Jilinde program.

PrEP Watch was created and is maintained by AVAC, a non-profit organization based in New York that uses education, policy analysis, advocacy and a network of global collaborations to accelerate the ethical development and global delivery of new and emerging HIV prevention options as part of a comprehensive response to the HIV/AIDS pandemic. AVAC receives no money from pharmaceutical companies, including Gilead Sciences. If you have a comment or suggestion regarding the content of this site, click here to contact us. Read our privacy policy.